Wistar Wire: Funding

Ben Leach
Meenhard Herlyn, D.V.M., D.Sc.
Meenhard Herlyn, D.V.M., D.Sc.
Wistar’s Dr. Meenhard Herlyn leads researchers from The Wistar Institute and the University of Pennsylvania to develop new therapies for melanoma.
Cancer, Funding, Melanoma
Ben Leach
After an extensive review, the National Cancer Institute recommended that The Wistar Institute Cancer Center receive $14.9 million in funding over the next five years to support infrastructure and research facilities.
Cancer, Funding
Ben Leach
From big events to new scientists and scientific breakthroughs, take a look back at all that has happened at The Wistar Institute in 2013.
Darien
In this latest NIH project grant, The Wistar Institute's Dr. Meenhard Herlyn brings together cutting-edge scientists from Wistar and the University of Pennsylvania to tackle melanoma drug resistance.
Cancer, Funding, Melanoma